Page results
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Information about staff who work in the Macmillan Support and Information Service.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
This page explains what an intra-oral scanner is and what it is used for.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Patient information on managing pain
File results
-
FOI/2022/0770 - Parking operations, impact, and parking charge notices issued
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0764 - Patients treated for drinks spiked/ spiked by needle injection
-
FOI/2022/0763 - Treatment of dermatological conditions
-
FOI/2022/0672 - Data Centre
-
FOI/2022/0677 - Documents relating to the lift being out of order (RLHIM Lift 2 by reception)
-
FOI/2022/0675 - Drug treatment for Paediatric patients (ages 0-16)
-
FOI/2022/0674 - Maternity locum staffing
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0665 - Formal patient/ family complaints